Accession Number: | 0001209191-21-012049 |
Date: | 2021-02-16 |
Issuer: | DECIPHERA PHARMACEUTICALS, INC. (DCPH) |
Original Submission Date: |
HOERTER STEVEN L.
C/O DECIPHERA PHARMACEUTICALS, INC.
200 SMITH STREET
WALTHAM, MA 02451
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
STOCK OPTION (RIGHT TO BUY) | 47.79 | 2021-02-16 | deemed execution date | A | 210,000 (d) | 2031-02-15 | common stock 210,000 | $47.79 | 210,000 | direct |
ID | footnote |
---|---|
f1 | this stock option was issued pursuant to the issuer's 2017 stock option and incentive plan. the option shall vest in equal monthly installments over four years, beginning on march 16, 2021. |